Our results suggest that L1CAM expression correlates with intermediate EMT phenotype and, in combination with CD133, defines a specific population of ovarian CSCs with increased radioresistance, enhanced spherogenic and clonogenic property, high tumor take rate, self-renewal capacity and fast tumor growth in vivo. This evidence concerns the gene L1CAM and neoplasm.